Frontlight ResearchEarly access
Trial site
Texas Oncology - Central/South Texas
- 10running trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Follicular lymphoma1 trial
- Mesothelioma1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 34 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting2 trials
- Lead sponsor
- Pfizer3 trials
- Bristol-Myers Squibb2 trials
- Amgen1 trial
- Artios Pharma Ltd1 trial
- Celgene1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Triple-negative breast cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026